GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Hologic, Inc. (HOLX) [hlAlert]

Rating:
Buy HOLX
down 20.00 %

Hologic, Inc. (HOLX) upgraded to Buy with price target $82 by Sun Trust Rbsn Humphrey

Posted on: Thursday,  Feb 14, 2008  8:25 AM ET by Sun Trust Rbsn Humphrey

Sun Trust Rbsn Humphrey rated Buy Hologic, Inc. (NASDAQ: HOLX) on 02/14/2008, when the stock price was $15.56. Since then, Hologic, Inc.
has lost 20.00% of its value until Sun Trust Rbsn Humphrey rated HOLX Neutral on 05/05/2009, when the price was $12.45.
If you would have followed this Sun Trust Rbsn Humphrey's recommendation on HOLX, you would have lost 20% of your investment in 446 days.

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women's health care. The systems are used by more leading medical schools, universities and osteoporosis opinion leaders than any other bone densitometer.

We provide equity research coverage on more than 300 companies in select core industries and sub-sectors with above-average growth potential. Our focused approach allows our analysts to have deep knowledge of industries, companies and markets they cover, enabling them to deliver highly insightful research and sound advice. With our expertise and thoughtful, diligent approach, our equity research positions you to make well-informed decisions that contribute to your success.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/1/2013 8:25 AM Sell
None
23.72
as of 12/24/2008
1 Week down  -4.09 %
1 Month up  10.33 %
3 Months up  25.32 %
1 YTD up  9.41 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/16/2012 8:25 AM Hold
None
19.42
5/5/2009 8:25 AM Hold
None
12.45
2/14/2008 8:25 AM Buy
None
15.56 20.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy